SCHEMBL7064594

SCHEMBL7064594

O=C(O)c1ccc(OCc2ccccc2)c(Cc2ccccc2)c1Br

nearest known ligand 0.55

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ FOLH1 Q04609 4/20 0.55
▸ L3MBTL1 Q9Y468 3/20 0.50
▸ ALDH1A1 P00352 2/20 0.50
▸ KDM4E B2RXH2 1/20 0.50
▸ POLB P06746 1/20 0.50
▸ MCL1 Q07820 2/20 0.47
▸ TDP1 Q9NUW8 2/20 0.47
▸ MAPT P10636 1/20 0.47
▸ CYP2C9 P11712 1/20 0.47
▸ CYP2C19 P33261 1/20 0.47
▸ SMN1; SMN2 Q16637 1/20 0.47
▸ PTGER1 P34995 3/20 0.46
▸ CHRM4 P08173 1/20 0.44
▸ CHRM3 P20309 1/20 0.44
▸ CLCN2 P51788 1/20 0.44
▸ CTSV O60911 1/20 0.43
▸ CTSL P07711 1/20 0.43
▸ SGMS2 Q8NHU3 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27703867 0.82 L3MBTL1 (0.63) FOLH1L3MBTL1ALDH1A1KDM4EPOLB
SCHEMBL9158071 0.78 FOLH1 (0.76) FOLH1L3MBTL1ALDH1A1KDM4EPOLB
SCHEMBL9679320 0.77 MAPT (0.60) FOLH1L3MBTL1TDP1MAPTCYP2C9
SCHEMBL21483694 0.77 L3MBTL1 (0.56) FOLH1L3MBTL1ALDH1A1KDM4EPOLB
SCHEMBL10089235 0.76 FOLH1 (0.69) FOLH1L3MBTL1ALDH1A1KDM4EPOLB
SCHEMBL27828998 0.76 CTSV (0.51) FOLH1L3MBTL1ALDH1A1KDM4EPOLB
SCHEMBL9123233 0.76 MAPT (0.71) FOLH1L3MBTL1TDP1MAPTCYP2C9
SCHEMBL3174598 0.76 ALDH1A1 (0.50) FOLH1L3MBTL1ALDH1A1KDM4EPOLB
SCHEMBL384896 0.76 FOLH1 (0.68) FOLH1L3MBTL1ALDH1A1KDM4EPOLB
SCHEMBL16898127 0.75 FOLH1 (0.58) FOLH1L3MBTL1ALDH1A1KDM4EPOLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1313696-A2 AMINO(OXO)ACETIC ACID PROTEIN TYROSINE PHOSPHATASE INHIBITORS ABBOTT LABORATORIES (US) 2003-05-28 — — EP disclosed
US-20020035137-A1 Amino (oxo) acetic acid protein tyrosine phosphatase inhibitors ABBOTT LABORATORIES 2002-03-21 — — US disclosed
WO-2002018323-A2 AMINO(OXO)ACETIC ACID PROTEIN TYROSINE PHOSPHATASE INHIBITORS ABBOTT LABORATORIES (US) 2002-03-07 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020035137-A1 Amino (oxo) acetic acid protein tyrosine phosphatase inhibitors PPM1A, PTPRO, PTP4A1 FOLH1 3410/4885L3MBTL1 3452/4885ALDH1A1 299/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback